LFT Lument shares climb despite sharp Q4 2025 EPS miss as investors bet on longterm business improvements CMS Energy CMSC Notable Move Q4 2025 EPS Misses Views SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading PFGC Performance reports Q1 2026 EPS miss of 119 percent shares trade nearly flat on muted investor reaction AR Antero Q4 2025 EPS misses estimates by 166 percent shares dip 094 percent following quarterly earnings release